A former Scripps Health employee is charged with stealing the personal information of dying patients for use in filing fraudulent benefits claims.
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
COVID-19 vaccine leader Moderna is joining the big leagues.
The Food and Drug Administration (FDA) will weigh full approval for the Pfizer-BioNTech COVID-19 vaccine in people aged 16 and older by January, the companies announced Friday.
An expert panel unanimously voted that Biogen’s controversial Alzheimer’s drug does not provide more benefit to patients than supportive care.
The Food and Drug Administration’s acting commissioner, Janet Woodcock, is taking the highly unusual step of asking for a federal investigation of doctors within her own agency who met with the makers of an Alzheimer’s drug prior to the medicine’s FDA approval.
U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug.
During a virtual hearing, Ms. Holmes’s lawyers and the U.S. attorney’s office in Northern California continued months of finger-pointing over who is to blame for the inability to access the blood-test database. Called the Laboratory Information System, it recorded data points on millions of Theranos blood tests but became inaccessible in 2018 under circumstances the prosecution and defense disagree about.
The new findings “reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally,” said J&J Chief Scientific Officer Paul Stoffels.
Walgreens administered 25M COVID-19 vaccines and tells investors the pace will slow in the coming weeks and months.
Walmart has launched a private brand of analog insulin, the company announced Tuesday. The insulin injection, manufactured by Novo Nordisk, and FlexPen, offered through Walmart’s ReliOn brand, will be available in the stores' pharmacies this week.
The recent approval of a high-price Alzheimer’s drug is raising questions about who will have access to a treatment that could cost Medicare billions of dollars in coming years.
-Infectious disease experts are weighing the need for booster shots of the Pfizer/BioNTech or Moderna mRNA-based vaccines for Americans who received Johnson & Johnson's one-dose vaccine due to the increasing prevalence of the more contagious Delta coronavirus variant
Johnson & Johnson has agreed to pay $230 million to the state of New York to resolve an opioid lawsuit slated to go to trial Tuesday, as negotiations intensify with the company and three drug distributors to clinch a $26 billion settlement of thousands of other lawsuits blaming the pharmaceutical industry for the opioid crisis.
The Food and Drug Administration (FDA) on Friday added a warning to the literature that accompanies Pfizer Inc/BioNTech and Moderna COVID vaccine shots to indicate the rare risk of heart inflammation after its use.
U.S. health officials have paused the distribution of two Eli Lilly & Co. COVID-19 monoclonal antibody treatments because of data showing that they aren’t effective against virus variants that are becoming increasingly common across the country.
Most Americans would be shocked to learn that millions of doses of poor-quality and potentially harmful generic drugs are being imported into the United States each year.
Financer and philanthropist Michael Milken weighed in on COVID-19 treatments during an exclusive interview with “Mornings with Maria” on Tuesday and argued that “American science has won.”
More than 80 million people — a record number — have health coverage through Medicaid and the Children’s Health Insurance Program, as enrollments surged due to Covid-19, according to new data released Monday by the Centers for Medicare and Medicaid Services.
St. Joseph's/Candler, one of the largest hospital systems in Savannah, Georgia, confirmed it was hit with a ransomware attack on Thursday morning.